Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Qualigen Therapeutics, Inc. | SVP/Chief Medical Officer | Stock Option (Right to Buy) | 102K | Jul 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QLGN | Qualigen Therapeutics, Inc. | Jul 11, 2022 | 1 | $0 | 4 | Aug 4, 2022 | SVP/Chief Medical Officer |
QLGN | Qualigen Therapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | SVP/Chief Medical Officer |
QLGN | Qualigen Therapeutics, Inc. | May 17, 2021 | 1 | $0 | 4 | May 18, 2021 | SVP/Chief Medical Officer |
QLGN | Qualigen Therapeutics, Inc. | May 17, 2021 | 0 | $0 | 3 | May 17, 2021 | SVP/Chief Medical Officer |